Align Technology -- How the Business Works
Align Technology is the dominant clear aligner company, best known for the Invisalign brand.
The business operates two segments: Clear Aligners (~80% of revenue) and Systems and Services
(~20%), which includes iTero intraoral scanners and Exocad CAD/CAM software. Align holds
~55-60% global clear aligner market share in an ~$8-9B TAM growing at ~20% CAGR -- no
competitor exceeds 10% share globally. The company has treated 22M+ patients, creating an
unmatched AI and clinical data moat that feeds its ClinCheck treatment planning software.
The iTero-ClinCheck-Invisalign ecosystem creates meaningful switching costs for orthodontists
and GPs. FY2025 revenue was $4.04B (+0.9% YoY) with non-GAAP EPS of $10.51 (+12.6% YoY)
and FCF of $491M (-21% YoY). The stock trades at $170.60 with a composite score of 6.5/10
(Watchlist -- dominant position at reasonable valuation, but low growth warrants patience).
FY2025 Free Cash Flow
$491M
-21% YoY | 12.2% FCF margin
Price / Composite Score
$171 / 6.5
Watchlist -- patience warranted
Clear Aligner Market Share
~55-60%
$3.25B in ~$8-9B TAM (+20% CAGR)
Non-GAAP Op Margin
22.7%
Q4 reached 26.1% | +90bps YoY
How Align Technology makes money -- two-segment medical device platform
The Align Business Model -- Two Revenue Segments
Clear Aligners (Invisalign)
~80% of Revenue
$3,245M (FY2025) | +0.5% YoY | ~55-60% global share
Comprehensive (adults), Moderate, Lite, Express, First (kids)
Sold per-case to orthodontists and GPs worldwide
Systems and Services (iTero / Exocad)
~20% of Revenue
$790M (FY2025) | +2.7% YoY | ~30-35% IOS share (#1)
iTero Lumina scanners + Exocad CAD/CAM software
Lumina at ~86% of full system units by Q4
Ecosystem Flow -- iTero Scan to Invisalign Treatment
iTero Scan
3D digital impression of teeth
→
ClinCheck AI
AI treatment plan (22M+ patient data)
→
Invisalign Fabrication
Custom aligners at scale
→
Patient Treatment
6-18 months | data feeds back to AI
Key Channels and Customer Segments
Orthodontists
Traditional core channel -- highest case complexity and ASPs
GPs / DSOs
~25% of volume, growing 20%+ YoY -- structural channel shift
Teens and Kids
+13% YoY volume -- Invisalign First driving secular growth
The ecosystem is the moat, not the patent portfolio:
Align has built a self-reinforcing flywheel -- iTero scanners feed patient data into
ClinCheck AI, which improves treatment planning accuracy with every case (22M+ patients
treated), which drives doctor preference for Invisalign, which incentivizes iTero
adoption. This ecosystem lock-in is why no competitor exceeds 10% global share despite
Invisalign patents largely expired. The data moat compounds: each new case makes
ClinCheck marginally better, raising the bar for competitors. SmileDirectClub failed
precisely because it tried to bypass the doctor-led ecosystem. Competitors like
Straumann (ClearCorrect) and Envista (Spark) lack both the data scale and the
integrated scanner-software-aligner platform.
Revenue segmentation from Align Technology earnings reports and investor presentations via Daloopa.
Revenue breakdown -- Clear Aligners flat, Scanners decelerating from peak
Annual Revenue Segmentation (USD Millions, Calendar Year)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Clear Aligners | $3,247M | $3,073M | $3,199M | $3,230M | $3,245M |
| YoY Growth | -- | -5.4% | +4.1% | +1.0% | +0.5% |
| Systems and Services | $706M | $662M | $663M | $769M | $790M |
| YoY Growth | -- | -6.2% | +0.1% | +16.0% | +2.7% |
| Total Revenue | $3,953M | $3,735M | $3,862M | $3,999M | $4,035M |
| Total YoY Growth | -- | -5.5% | +3.4% | +3.5% | +0.9% |
Core Clear Aligner revenue has been essentially flat at ~$3.2B for four years.
All incremental growth has come from Systems and Services (iTero Lumina cycle). Scanner
growth decelerated sharply from +16% in FY2024 to +2.7% in FY2025 as the Lumina upgrade
wave matured (~86% penetration). Management guides 3-4% total revenue growth for FY2026.
The gap between ALGN revenue growth (+0.9%) and market CAGR (~20%) is the key concern --
long-tail competitors are collectively taking share.
Financial data from Align Technology earnings reports via Daloopa. FY2025 is calendar year ending December 31, 2025.
Geographic volume trends -- international strength, North America soft
Clear Aligner Volume by Region (Directional, from Earnings Calls)
| Region | Q3 2025 Vol YoY | Q4 2025 Vol YoY | Key Commentary |
|---|---|---|---|
| EMEA | Double-digit | Double-digit | Record Q4; strength in Iberia, Nordics, UK |
| APAC | Double-digit | Double-digit | Record Q4 in China, India, Korea; teens strength |
| Latin America | Growing | Double-digit | Surpassed 1M patients treated milestone |
| North America | Down YoY | Stable/Slight Up | Retail soft; DSOs grew double-digit, offsetting |
Geographic divergence is the key story:
EMEA, APAC, and Latin America are all growing double digits on volume while North America
retail stagnates. DSOs (dental service organizations) are the structural offset -- ~25%
of volume and growing 20%+. Q4 2025 was the best Americas growth rate since 2021. Only
~15% of orthodontic cases globally use clear aligners today, meaning the primary
competition is not other aligner companies but the status quo (traditional wires and
brackets).
Geographic volume trends from ALGN earnings call commentary (Q3 and Q4 2025). ALGN does not disclose revenue by geography.
Competitive position -- dominant-firm oligopoly in clear aligners
Market Share Across Segments (Oligopoly Gate: PASS)
| Market Segment | Market Size | ALGN Share | Next Largest | Assessment |
|---|---|---|---|---|
| Clear Aligners (Global) | ~$8-9B | ~55-60% | Straumann ~5-8% | Dominant -- no rival above 10% |
| Intraoral Scanners (IOS) | ~$1.1-1.5B | ~30-35% | 3Shape ~25-30% | Leader in tighter oligopoly |
| Total Orthodontics | ~$25-30B | ~13-16% | Wires/brackets majority | Clear aligners still only ~15% of cases |
Moat Sources -- Compounding Data and Ecosystem Advantages
22M+
Patients Treated
AI/data moat deepens with each case
Ecosystem
iTero + ClinCheck + Invisalign
Integrated platform = switching cost
Brand
Invisalign = Category Name
Consumer pull drives doctor adoption
Scale
Manufacturing at Unmatched Scale
Competitors raising prices (ALGN is price-setter)
Market share estimates from industry research and ALGN investor presentations. Competitive commentary from Q4 2025 earnings call.
Competitive landscape -- clear aligner and scanner peers
| Company | Aligner Share | Scanner Share | Positioning | Threat Level |
|---|---|---|---|---|
| Align (ALGN) | ~55-60% | ~30-35% | Category creator, ecosystem leader | -- |
| Straumann (ClearCorrect) | ~5-8% | -- | Largest branded competitor, dental implant leader | Moderate |
| Envista (Spark) | ~3-5% | -- | Orthodontics portfolio, growing from low base | Low |
| 3Shape | -- | ~25-30% | Scanner-only, open ecosystem philosophy | Moderate (IOS only) |
| Dentsply Sirona | ~2-4% | ~15-20% | SureSmile aligners + Primescan scanner | Low |
| Long-tail / Regional | ~20-25% | -- | Hundreds of local brands collectively gaining | Key concern |
Market share from industry estimates and ALGN investor presentations. SmileDirectClub (DTC model) filed for bankruptcy in 2023, validating the doctor-led approach.